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CARP: Fishing for Novel Mechanisms
of Neovascularization
Susan E. Samaras1, Yubin Shi2 and Jeffrey M. Davidson1,3
Gene expression profiling of mouse skin wounds has led to the discovery of numerous target genes that may
have therapeutic or diagnostic value. Among these, cardiac ankyrin repeat protein (CARP, ankrd1) expression
was markedly and persistently elevated in several cutaneous compartments. This review summarizes the current
state of knowledge of CARP and its regulation in biological systems. In addition to its role as a nuclear
transcription cofactor in many cell types including vascular endothelium, CARP is also a structural component
of the sarcomere. CARP transcripts are prominent in cardiogenesis and muscle injury, and they are under
complex regulation by cytokines, hypoxia, doxorubicin, and other forms of stress. CARP overexpression in
wounds by adenoviral gene transfer leads to a high vascular density, and CARP exerts effects on endothelial
behavior. The unusual cellular distribution and actions of CARP make it a novel candidate gene in tissue repair.
Journal of Investigative Dermatology Symposium Proceedings (2006) 11, 124–131. doi:10.1038/sj.jidsymp.5650014
INTRODUCTION
Healing of wounds involves an orchestrated cascade of
events, and it requires a complex interplay between multiple
cell types that must respond to the initial insult with a
progressive change in their genetic programming. Beginning
with the activation of platelets and their release of clotting
factors and cytokines and ending with re-epithelization and
the final maturation and remodeling of the wound area, gene
expression profiles of all involved cell types are dynamic and
responsive to the ever-changing wound milieu. To ‘‘fish’’ for
novel genes involved in this process, cDNA subtractive
hybridization was performed in collaboration with Switch
Biotech AG, comparing intact skin and 1 day full-thickness
wounds in the mouse (Shi et al., 2005). Using this approach,
the expression of ankrd1, a gene which encodes the
transcriptional cofactor, cardiac ankyrin repeat protein
(CARP) was among several hundred genes that were found
to be highly induced in wounds. The time course of CARP
mRNA and protein expression, determined by quantitative,
real-time RT-PCR and Western blot analysis, showed that
they were significantly increased within hours, reaching peak
levels by 15 hours and remaining elevated for 2 weeks during
the wound healing process (Figure 1). Furthermore, immu-
nohistochemistry and in situ hybridization for CARP protein
and mRNA in day 1 wounds revealed that monocytes, cells of
the epidermis and the vasculature, and skeletal muscle had
increased expression (Shi et al., 2005) (Figure 2). Thus,
changes in the abundance of this transcriptional cofactor may
modulate the gene expression profiles in these cells. This
review will focus on what is known about CARP and its
actions, and how it affects its role in neovascularization.
BACKGROUND
The gene encoding CARP was initially identified in a screen
for cytokine-inducible factors in microvascular endothelial
cells (Chu et al., 1995). Found on chromosome 10 in humans
and 19 in mouse, the ankrd1 gene structure is highly
conserved, with nine exons and a canonical TATA box in
the proximal promoter which, to date, appears to produce a
single transcript (Chu et al., 1995; Jeyaseelan et al., 1997). No
alternative splicing of the RNA has been described. Other
canonical response elements identified in the 50 flanking
sequence of CARP include GATA sites, E-box elements, a
CCAC box, a CAGA box, and M-CAT, activator protein-1 and
SP-1 binding sites (Baumeister et al., 1997; Kuo et al., 1999)
(Figure 3). These sites exert both positive and negative
regulation of CARP. A short 50 untranslated region (UTR) and
a longer 30 UTR, which contains a conserved degradation
motif, characterize the 10.6 kb CARP pre-mRNA. The
primary transcript containing nine exons is processed to
encode a 319 amino-acid protein with a molecular weight of
36 kDa. CARP protein sequence and domain organization is
124 Journal of Investigative Dermatology Symposium Proceedings (2006), Volume 11 & 2006 The Society for Investigative Dermatology
Received 1 February 2006; revised 7 April 2006; accepted 10 April 2006
1Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; 2Department of Surgery, Division of Plastic Surgery, Pediatric
Surgery Research Laboratory, Stanford University, Stanford, California, USA and 3Research Service, VA Tennessee Valley Healthcare System, Nashville,
Tennessee, USA
Correspondence: Dr Jeffrey M. Davidson, Department of Pathology C-3321 MCN, Vanderbilt University School of Medicine, 21st and Garland Sts., Nashville,
Tennessee 37232-2561, USA. E-mail: jeff.davidson@vanderbilt.edu
Abbreviations: ANF, atrial natriuretic factor; CARP, cardiac ankyrin repeat protein; CASQ-2, cardiac calsequestrin-2; DOX, doxorubicin; EGF, epidermal growth
factor; HMVEC, human microvascular endothelial cell; MARP, muscle ankyrin repeat protein; TNC, troponin C; TGF-b, transforming growth factor-beta; VEC,
vascular endothelial cell; VSMC, vascular smooth muscle cell; 30-UTR, 30 untranslated region
highly conserved among mammalian species. Analysis of the
peptide sequence identifies a bipartite nuclear localization
signal, a PEST-like sequence (a four amino acid sequence
associated with rapidly degraded proteins), four highly
conserved ankyrin-like repeats and another less conserved
half repeat, and numerous potential modification sites for
phosphorylation, glycosylation, and myristilation (Chu et al.,
1995; Jeyaseelan et al., 1997) (Figure 3). Ankyrin-repeats
have been found in proteins that are involved in protein–-
protein interactions, including those characterized as cyclin-
dependent kinase inhibitors (p16, p18, and p19), develop-
mental regulators (Notch and IkBa), and transcription factors
(Swi6 and GABPa, b) (reviewed in Sedgwick and Smerdon,
1999). The family of ankyrins is involved in binding and
organization of many cytoplasmic proteins (Mohler and
Bennett, 2005a, b). CARP belongs to a three-member family
of muscle ankyrin repeat proteins or MARPs that also
includes AARP/ankrd2 and the diabetes-associated diabetic
ankyrin repeat protein (DARP) (Ihara et al., 2002; Miller et al.,
2003). The degradation motif located in the 30-UTR of the
mRNA (Baumeister et al., 1997; Jeyaseelan et al., 1997), the
PEST-like protein degradation sequence (Chu et al., 1995;
Jeyaseelan et al., 1997), and the potential for multiple forms
of protein modification suggest that the expression and
activity of this protein is highly regulated at the post-
transcriptional level. Indeed, the steady-state levels of both
CARP protein and mRNA are significantly increased by b-
adrenergic agonists (Zolk et al., 2003), but little is known
about the mechanisms involved.
EXPRESSION STUDIES
CARP is sharply upregulated during cardiomyogenesis (Zou
et al., 1997; Kuo et al., 1999). Lower, constitutive CARP
expression in adult mice is most prominent in the heart,
whereas lung and skeletal muscle transcripts are also
detected by Northern blot analysis. CARP mRNA is also
found in the highly vascularized placenta. Using a 2.5 kb
CARP promoter-driven lacZ transgene, embryonic expression
appears to be primarily localized in the developing heart,
where CARP expression has been studied most extensively.
Figure 1. Comparison of CARP mRNA and protein levels in intact skin and
excisional wounds in mice. (a) Time course of CARP mRNA levels in normal
mice after wounding. Quantitative real-time RT-PCR showed that CARP
transcripts were dramatically upregulated during the first day after wounding
and increased expression was maintained between 25- and 30-fold from day
3 to day 14 after wounding. PCR reactions were performed three times.
(b) Western blot analysis of CARP protein after wounding. Fifty micrograms of
lysate protein from mouse skin, prepared at indicated times after wounding,
were fractionated by SDS-PAGE. (c) CARP protein (top row) was
normalized to b-actin (bottom row) and band intensities were plotted.
Reproduced from Shi et al. (2005, Am J Pathol 166: 303–12) with permission
from the American Society for Investigative Dermatology.
Figure 2. Immunostaining and in situ hybridization of CARP in mouse skin wounds. (a) Expression of CARP in a day 3 mouse skin excisional wound.
The red dashed line indicates the boundary between wound and normal tissue. Higher magnification images of CARP-positive cells are shown in (b) hair
follicles (HF, and (c) inflammatory cells in 1 day wounds; and (d) epidermis (EP and (e) skeletal muscle (MU in 3 day wounds. (f) In situ hybridization for CARP
mRNA in mouse 1 day skin wounds showed positive signals (dark color) in the skeletal muscle (red arrow), blood vessels (black arrow), and epidermis
(yellow arrow). The red dashed line indicates the basement membrane. High magnification of the inflammatory cells (red arrow) and the vessel are shown.
Reproduced from Shi et al. (2005, Am J Pathol 166: 303–12) with permission from the American Society for Investigative Dermatology.
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Removal of the cardiogenic homeobox gene Nkx2.5 using
knockout strategies results in selectively reduced CARP
expression (Zou et al., 1997). This result suggests that, at
least in cardiac muscle, CARP is downstream of the Nkx2.5
pathway and that Nkx2.5 either directly or indirectly
regulates CARP expression. GATA 4, a direct target of
Nkx2.5, is also involved in cardiac development and has
been shown to regulate CARP expression through direct
binding to canonical response elements in the CARP
proximal promoter (Kuo et al., 1999; Maeda et al., 2002).
CARP expression is increased in several cardiomyopathies
and in cardiovascular injury. Left ventricular dilated cardio-
myopathy and ischemic cardiomyopathy in humans exhibit
increased CARP expression as compared to non-affected
human donor hearts (Zolk et al., 2002). In an acute model of
cardiac hypertrophy induced by ventricular pressure over-
load in rats, CARP mRNA was increased 8 days after banding
of the descending aorta (Aihara et al., 2000a). In a well-
characterized, in vitro model of cardiac hypertrophy that
involves activation of fetal genes in cardiac myocytes by a1-
adrenergic stimulation, a1-adrenergic agonists increase en-
dogenous CARP expression whereas antagonists lower
expression in myocytes. Analysis of the CARP proximal
promoter has identified TEF-1 and GATA 4 binding to MCAT
and GATA elements, respectively, as the transcriptional
mediators of the a1-adrenergic stimulation (Maeda et al.,
2002). Vascular smooth muscle cells (VSMCs) in rat athero-
sclerotic lesions exhibit increased CARP expression, and
similar induction is observed in both VSMCs and vascular
endothelial cells (VECs) of collateral arteries that form
following femoral artery occlusion (Boengler et al., 2003;
de Waard et al., 2003). Balloon injury of the aorta in rats also
increases CARP expression (Kanai et al., 2001). Transforming
growth factor beta (TGF-b) signaling induces CARP mRNA,
and evidence implicates binding of the Smads to the CAGA
element in the CARP promoter as the transduction mediator
(Kanai et al., 2001). However, our own data employing
selective inhibitors in the MS-1 vascular endothelial cell line
suggest dominant signaling through the p38 mitogen-acti-
vated protein kinase pathway and a lesser contribution of
Smad signaling (Y Shi, unpublished).
CARP is also an acronym for cardiac adriamycin-
responsive protein. Adriamycin (doxorubicin; DOX) is a
chemotherapeutic agent that can produce collateral damage
to the myocardium of patients undergoing chemotherapy,
and extravasation of the drug during administration produces
severe chemical injury to the skin and adjacent tissues. The
mechanism of DOX toxicity is primarily by the hyper-
induction of oxygen radicals, leading to oxidative stress and
programmed cell death/apoptosis (Singal et al., 2000).
Paradoxically, DOX treatment can cause both induction (in
vivo) and repression (in vitro) of CARP expression. In piglets,
DOX treatment results in left ventricular dilated cardiomyo-
pathy that is associated with increased CARP mRNA and
protein 20 days after a single intravenous injection of the drug
(Torrado et al., 2004). A more recent microarray analysis of
Figure 3. Organization of the CARP gene, mRNA, and protein. The CARP gene (ankrd1) is located on chromosome 10 in the human and 19 in the mouse.
The bulk of the identified regulatory sites in the CARP promoter lie within B600 bp of the transcription start site (top line). The site labeled as MCAT1 has
been identified by one group as a constitutively active promoter element and by another laboratory as a response element for the transcription factor GADD153.
The primary transcript of the gene encoded by nine exons is a 10.6 kb mRNA with a short 50UTR, open reading frame, and a long 30UTR with a canonical
RNA degradation sequence (middle line). Exons 5–8 encode four ankyrin repeat elements (bottom line), the second of which includes a sequence reported
to bind to the giant muscle protein, titin (shaded horizontal bar). NH2-terminal to the ankyrin repeats, the diagram illustrates the location of two putative nuclear
localization signals (NLS, solid bars) and the PEST sequence (diagonal stripes) that targets ubiquitinated proteins for degradation. The structures of the mRNA
and protein are consistent with molecules that undergo high turnover rates. Putative phosphorylation, myristylation, and glycosylation sites have not been
confirmed and are thus not indicated.
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DOX-sensitive transcription products in the heart compares
the effects of a single, acute intraperitoneal injection of DOX
to weekly intraperitoneal injections of smaller doses (Yi et al.,
2006). Acute DOX increases CARP mRNA significantly, and
quantitative, real-time RT-PCR confirms a 4.53-fold induc-
tion. However, chronic, low-dose DOX exposure does not
result in a significant change in cardiac CARP mRNA. In
contrast, cultured cardiomyocytes treated with DOX show a
sensitive, dose-dependent repression of CARP that is asso-
ciated with acute oxidative stress. This effect has been
attributed to the action of hydrogen peroxide on a H7-
sensitive serine/threonine kinase pathway that interacts with
a proximal M-CAT element in the human CARP promoter
(Aihara et al., 2000b). In a separate study, DOX-treated
embryonic heart-derived H9c2 cells developed oxidative
stress followed by apoptosis that correlated with the level of
GADD153 (CHOP-10), a member of the CCAAT/enhancer-
binding protein (C/EBP) family of transcription factors (Han
et al., 2005). The level of CARP mRNA was found to be
inversely proportional to that of GADD153. Furthermore, co-
transfection of a GADD153 expression vector with a CARP
promoter (206)-driven luciferase reporter construct resulted
in a dose-dependent decrease in luciferase activity. These in
vitro data suggest direct regulation of CARP transcription by a
GADD153 response element in the proximal promoter.
The opposing DOX regulation of myocardial CARP
expression in vivo and in vitro could be related to the timing
of analysis. Acute downregulation of CARP by oxidative
stress and cardiomyocyte apoptosis could lead to increased
mechanical stress and a rebound in CARP expression in
surviving cardiomyocytes during the reparative phase. In
addition, many forms of myocardial injury can elicit
expression of TGF-b and tumor necrosis factor alpha-a, both
of which induce CARP expression ((Kanai et al., 2001) and
Shi, unpublished)). The in vivo induction of CARP may be
cytoprotective, as suggested by the ability of CARP over-
expression to protect H9c2 cells from hypoxia-induced
apoptosis (Han et al., 2005) and by our preliminary evidence
that increased CARP also protects VEC from DOX toxicity
(Shi et al., unpublished) and serum starvation (Shi et al.,
2005).
CYTOPLASMIC CARP
CARP is localized in the nuclei of striated muscle, and it has
also been colocalized with the giant filamentous polypeptide,
titin in the I-band of the sarcomere (Miller et al., 2003; Kojic
et al., 2004). All three MARP proteins have been shown to
associate to the N2A epitope of titin through binding of their
ankyrin repeats to form the N2A signaling complex, which is
also composed of myopalladin (Bang et al., 2001) and the
calpain protease, p94 (Figure 4). Passive muscle stretch
induces increased immunostaining for the MARPs both in the
nucleus and the I-band, with DARP staining also increasing in
the intercalated discs (Miller et al., 2003). The concept that
CARP is responsive to mechanical stress is consistent with its
cytoplasmic distribution in striated muscle (cardiac and
skeletal). There is still much to learn about the role of MARPs
in striated muscle, and we speculate that these ankyrin repeat
proteins may link myofibrillar stretch signals to the transcrip-
tional regulation of muscle gene expression.
Cytoplasmic CARP may also participate in regulating
cardiac muscle contractility by its interaction with cardiac
calsequestrin-2 (CASQ-2), a protein that stores calcium for
muscle function (Torrado et al., 2005). Five distinct CASQ-2
binding regions have been identified in CARP: three in the
NH2-terminus and two within the ankyrin repeat region.
None of the CASQ-2 binding regions overlap the CARP–titin
interaction domains (see Figure 3). Without more functional
data, the significance of this interaction can only be
conjectured; however, overexpression of CARP in engineered
heart tissue results in a significant decrease in the force of
contraction stimulated by increasing doses of calcium (Zolk
et al., 2003). This attenuation in calcium-stimulated contrac-
tion could involve more extensive CARP binding to CASQ-2,
thereby sequestering calcium in the sarcoplasm and making it
unavailable for muscle contraction.
OVEREXPRESSION STUDIES
To investigate its actions in the wound-healing process, CARP
was transduced into both full-thickness excisional wounds
and an experimental sponge granulation tissue model by
adenovirus-CARP infection (Shi et al., 2005). In these models,
CARP significantly increased neovascularization, blood
perfusion, and the abundance and organization of migrating
VEC. In both rabbit ear excisional wounds and ischemic rat
skin wounds, exogenous expression of CARP increased
neovascularization and blood perfusion, as assessed by
histological analysis of vessel size and numbers as well as
laser Doppler perfusion imaging. In an experimental granula-
tion tissue model in which polyvinyl alcohol sponges are
implanted subcutaneously in rats, sponge injection with
adenovirus-CARP resulted in increased vascularization as
assessed by CD34 staining of vessels. In flk-1/lacZ knock-in
mice 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside
staining showed a significant increase in lacZ-positive
endothelial cells in the advenovirus-CARP injected sponges
relative to those injected with a control virus.
POTENTIAL ACTIONS OF CARP
As observed in striated muscle, CARP protein has been
identified in both the cytoplasm and the nucleus of VSMC
and VEC. Although CARP-protein associations within these
cells have not been determined, the identification of titin-like
proteins in smooth muscle and non-muscle cell types suggest
a possible commonality with the CARP associations seen in
striated muscle. Smitin, a 700 kDa titin-like protein, is
associated with the contractile apparatus in smooth muscle
(Kim and Keller, 2002; Chi et al., 2005). In non-muscle cell
types, transfected, labeled z-repeats of titin have been
localized to the dense bodies of stress fibers (Ayoob et al.,
2000). Overexpression of the z-repeat constructs results in the
loss of stress fibers, suggesting the presence of a titin-like
protein in non-muscle that acts to organize the stress fibers,
similar to the sarcomere organizing function of titin in which
CARP appears to play a role (Bang et al., 2001). In non-
muscle cells, titin-like proteins have also been identified in
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the nucleus, in association with spindle fibers during mitosis
(Wernyj et al., 2001). As yet, the association of CARP with the
non-muscle titin-like proteins or any other proteins and the
effects of protein–protein interactions on CARP activity have
not been explored.
CARP expression is increased in VSMC and VEC following
wounding, but its effects are not certain. CARP overexpres-
sion studies in vivo and in vitro have provided some insights
into its function. As reported above, overexpression in
wounds and experimental granulation tissue increases
angiogenesis and vasculogenesis, leading to increased blood
perfusion, which appears to be due to the enhanced
infiltration of vascular endothelium and endothelial precursor
cells (Shi et al., 2005). Support for this concept is provided by
the effects of CARP overexpression in human microvascular
endothelial cells (HMVEC). CARP overexpression does not
affect proliferation in tissue, as assessed by proliferating cell
nuclear antigen staining (Shi, unpublished). Preliminary
findings show that overexpression of CARP in vitro results
in the same or lower proliferation than HMVEC treated with
either a control virus or nothing. Cell migration is CARP-
responsive. Electrical cell-substrate impedance sensing was
used to examine migration of CARP-transduced cells after
ablation of a portion of the cell monolayer with a brief
electrical pulse (Shi et al., 2005). The rate and extent of
monolayer restoration (i.e., cell migration) as measured by
impedance, was greater in the CARP-overexpressing cells.
Additionally, the haptotactic activity of the HMVEC in
response to EGF is also increased, indicating that CARP
increases the migration of VEC in response to cytokine
signaling. Furthermore, CARP is also capable of inducing
HMVECs tube formation, a measure of capillary endothelial
morphogenesis, in a MatrigelTM assay. This response is
partially abrogated with CARP small interfering RNA, further
supporting a direct role for CARP in endothelial cell
morphogenesis (Shi, unpublished).
Previous studies indicated that CARP is protective against
both hypoxia and oxidative stress-induced programmed cell
Figure 4. Schematic representation of identified regulatory pathways in CARP expressing cells. CARP is expressed in striated muscle (blue), vascular smooth
muscle (green) and VECs (yellow). Although the signaling pathways that regulate CARP expression are not completely defined, signaling molecules that
are known to be active are shown. Question marks indicate unknown pathways and/or signaling molecules. Transcription factors that positively (þ ) and
negatively () regulate transcription of the CARP gene are shown in the nucleus. CARP is located in the I-band portion of the sarcomere Z-disk in striated muscle,
in direct association with myopalladin and the N2A region of titin (enlarged inset). Cardiac calsequestrin-2 (CASQ-2) has also been reported to directly associate
with CARP. Mechanical stress increases CARP protein levels in the I-band (þ ) and in the nucleus (þ ) of the myofiber by mechanisms that implicate stretch-
activated channels and cell adhesion molecules such as the integrins. In cardiac muscle, a-adrenergic agonist-stimulated CARP transcription is, in part,
GATA 4 dependent. In contrast, b-adrenergic agonists do not stimulate CARP transcription but increase cellular CARP by stabilization of the protein and the
mRNA (þ ). Doxorubicin and hypoxia-induced reactive oxygen species act via H7-sensitive serine/threonine kinase and p38, respectively, leading to
induction of CHOP-10 (GADD153) and direct inhibition of CARP gene transcription. TGF-b, activin A and tumor necrosis factor alpha-a increase CARP
transcription. The signaling pathways in cardiac muscles have not been described. Activin A and TGF-b use a Smad-mediated pathway to increase CARP
transcription in vascular smooth muscle. In contrast, TGF-b signals via a p38-mediated pathway in VECs. CARP has been characterized as a negative
transcriptional cofactor. In cardiac myocytes, CARP overexpression results in decreased ANF, TNC and MLC 2v gene expression at least in part owing to
association with the YB-1 transcriptional activator. Transcriptional activation by CARP has not yet been described.
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death or apoptosis (Han et al., 2005). When human umbilical
vein endothelial cells are subjected to serum starvation, cells
transduced with CARP are able to survive better than those
transduced with either a control virus or nothing. Treatment
of human umbilical vein endothelial cells with DOX causes
oxidative stress and initiation of the apoptotic pathway by
inducing caspase 3. CARP transduction increases cell survival
that correlates with a decrease in basal- and DOX-induced
caspase 3 activity (Shi et al., unpublished). Thus, CARP may
increase vascular cell abundance by amplification of the
migratory stimulus while reducing the rate of apoptosis due to
oxidative stress or physiologic attrition.
Inasmuch as CARP is implicated in neovascularization,
understanding the signaling mechanisms that regulate its
expression becomes important. As mentioned above, CARP
mRNA and protein are upregulated by TGF-b signaling in
VSMC via a pathway that involves Smad factors (Kanai et al.,
2001). Smad 3 potently increases CAGA binding element-
dependent activity of a CARP promoter (1828)-driven
luciferase reporter whereas Smad 6, an inhibitory Smad,
inhibits TGF-b stimulated activity. Our unpublished data
suggest that both TGF-b and tumor necrosis factor alpha-a,
but not vascular endothelial growth factor or basic fibroblast
growth factor induce CARP expression in VEC. Though the
tumor necrosis factor alpha-a signal transduction pathway
has not yet been determined in these cells, we have
found that the TGF-b signaling induces CARP mRNA and
protein in VEC via the mitogen-activated protein kinase/p38
pathway rather than the Smad pathway. The p38 inhibitor
SB203580 and a dominant-negative form of p38 attenuate the
TGF-b induction of CARP mRNA but Smad 7, another
inhibitory Smad, has no effect (Shi et al., unpublished).
Similarly, CARP expression in cardiac myocytes is reported to
be specifically upregulated by p38 and a constitutively active
form of RAC 1 (Aihara et al., 2000a). Activation by both
factors is reportedly dependent on an M-CAT element within
the CARP proximal promoter. Thus, CARP appears to be
induced in endothelial cells by inflammatory cytokines and
not angiogenic factors. Furthermore, the same inducers
activate alternative signaling pathways in different cell types
(Table 1 and Figure 4).
Another serious gap in our knowledge of CARP is its
downstream effects. Although CARPs function in the cyto-
plasm of VEC and VSMC remains to be determined,
analysis of its nuclear function in cardiomyocytes suggests
that it acts as a transcriptional cofactor that regulates
expression of heart-enriched genes (Figure 4). CARP is
reported to interact with the ubiquitous transcription
factor YB-1 (Zou et al., 1997). Studies to date have
emphasized the role of this pairing in the downregulation
of transcriptional targets such as myosin light chain-2v via the
HF-1a element present in its promoter. Other cardiac-
enriched genes such as antinuclear factor, have shown
regulation by CARP overexpression (Jeyaseelan et al.,
1997), possibly by a similar mechanism. Thus, CARP-YB-1
interactions may serve as a prototype for targets of the
Nkx2.5 homeobox protein in ventricular cardiomyocytes.
Additionally, CARP expression is also associated with
circumstances of muscle regeneration, such as bupavicaine
injury and Duchenne muscular dystrophy (Nakada et al.,
2003) suggesting a transcriptional regulatory function in
skeletal muscle. Our preliminary gene expression profiling of
VSMC and HMVEC after CARP overexpression gives cre-
dence to the idea that CARP or its downstream targets are also
responsible for upregulation of a number of relevant genes in
these cells.
Table 1. Summary of CARP gene regulation
Stimulus
Transcription
factor Mediators
Promoter
target site
Effect
on CARP
Effect on gene
expression Reference
a-Adrenergic GATA4 — GATA Up Up Maeda et al. (2002)
— — GATA Up Down
TGF-b SMAD — CAGA Up Up Kanai et al. (2001)
TEF-1 — MCAT(1/3) Up Up
— p38, Rac1 MCAT2 Up Up Aihara et al. (2000a)
IL-1b — — — Up — Chu et al. (1995)
Hypoxia GADD153 P38 C/EBP? Down Apoptosis Han et al. (2005)
H2O2 — S/T kinase MCAT2 Down — Aihara et al. (2000b)
b-Adrenergic — PKA, CaMK — Up — Zolk et al. (2003)
TNF-a — — — Up — Shi, unpublished
TNF-a — — — Up — Chu et al. (1995)
TGF-b — p38 — Up — Shi, unpublished
Activin A — — — Up — de Waard et al. (2003)
TGF-b — — — Up — Boengler (2003)
CaMK, calmodulin-dependent protein kinase; CARP, cardiac ankyrin repeat protein; PKA, protein kinase A; TNF-a, tumor necrosis factor-alpha; TGF-b,
transforming growth factor-beta.
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Although the studies that have been discussed herein
describe CARP expression in several systems, these ap-
proaches do not define the role of endogenous CARP. As the
protein is massively upregulated during cardiomyogenesis
(Kuo et al., 1999), it may play a central role in the
organization of the sarcomere and/or the transcriptome of
the developing cardiomyocyte. In this respect, targeted
deletion of CARP might be expected to lead to a fatal
disruption of the cardiogenic program. Although lethality of
global CARP deletion needs to be confirmed, the use of a
conditional deletion in selected tissues or at selected sites
should greatly improve our understanding of the intrinsic
roles of the molecule. Currently, small interfering RNA
reagents in this laboratory appear to be able to abrogate
CARP-dependent effects such as endothelial morphogenesis.
These tools can be used to fill the serious gap in our
knowledge of CARPs downstream effects.
SUMMARY
Based on associations with elements of the sarcomere and the
transcriptional machinery, CARP appears to have both
cytoplasmic and nuclear roles. The presence of titin-like
proteins in smooth muscle and non-muscle cells suggests that
CARP or a related member of the MARP family could have
analogous functions in striated, smooth muscle and non-
muscle cell types. At the nuclear level, CARP is strongly
implicated as a transcriptional cofactor in regulation of
cardiovascular development and response to injury in a
variety of tissues. A number of studies show that oxidative
stress and several stress-induced signaling molecules mod-
ulate CARP in the context of its transcriptional activity, and its
own expression through promoter elements that are partially
characterized. The mode of action of CARP on target genes is
not well understood. The relationship between the cytoplas-
mic and nuclear sites of CARP interaction may have parallels
with the dual role of molecules such as b-catenin (Brembeck
et al., 2006), in which a structural element of the cytoplasm
transforms into a regulatory element when shuttled to the
nucleus. In the case of striated muscle, CARP is a key element
of a complex containing titin, CASQ-2 and other molecules,
which could be capable of relaying mechanical signals. It
remains to be determined whether nuclear translocation of
CARP contributes to mechanical or other stress responses.
Overexpression of CARP in cells and tissues suggests that it
could significantly contribute to the quality and extent of
tissue repair, particularly with respect to neovascularization.
It is not known whether these effects of excess CARP are a
direct reflection of its intrinsic role, and targeted down-
regulation or deletion of CARP will be necessary to define its
function. Regarding (cutaneous) wound repair, the pharma-
cologic action of CARP underscores the potential of gene
transfer to reveal heretofore unknown activities of genes, the
ability of adenoviral gene delivery to expand the wound healing
pharmacopeia to nuclear transcription factors, and the possible
presence of a novel mechanism for neovascularization.
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